CMS Targeting LTC Facility Overprescribing, Citing Antipsychotics
The Centers for Medicare and Medicaid Services is proposing a new Medicare requirement that consulting pharmacists serving long-term care facilities maintain independence from the facility to help avoid drug “overprescribing and overutilization.”
You may also be interested in...
A program launched in 2012, the National Partnership to Improve Dementia Care, is on its way to meeting goals of lowering the use of antipsychotic drugs in nursing homes by 15%, with 11 states already hitting that target.
CMS will not implement an earlier regulatory proposal requiring that consultant pharmacists maintain independence from long-term care facilities or drug firms at this point.
CMS’ proposal to reduce overprescribing in nursing homes draws cautiously favorable response from national pharmacist group, but long-term care pharmacy firm Omnicare argues the agency has not provided adequate justification for its plan.